Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:22
Revelation Biosciences Max Drawdown (5Y) : 100.0% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 100.0% |
| July 31, 2026 | 100.0% |
| June 30, 2026 | 100.0% |
| May 31, 2026 | 100.0% |
| April 30, 2026 | 100.00% |
| March 31, 2026 | 100.00% |
| February 28, 2026 | 100.00% |
| January 31, 2026 | 100.00% |
| December 31, 2025 | 100.00% |
| November 30, 2025 | 100.00% |
| October 31, 2025 | 100.00% |
| September 30, 2025 | 100.00% |
| August 31, 2025 | 100.00% |
| July 31, 2025 | 100.00% |
| June 30, 2025 | 100.00% |
| May 31, 2025 | 100.00% |
| April 30, 2025 | 100.00% |
| March 31, 2025 | 100.00% |
| February 28, 2025 | 100.00% |
| January 31, 2025 | 100.00% |
| December 31, 2024 | 100.00% |
| November 30, 2024 | 99.99% |
| October 31, 2024 | 99.99% |
| September 30, 2024 | 99.99% |
| August 31, 2024 | 99.99% |
| Date | Value |
|---|---|
| July 31, 2024 | 99.99% |
| June 30, 2024 | 99.99% |
| May 31, 2024 | 99.99% |
| April 30, 2024 | 99.98% |
| March 31, 2024 | 99.98% |
| February 29, 2024 | 99.98% |
| January 31, 2024 | 99.93% |
| December 31, 2023 | 99.87% |
| November 30, 2023 | 99.85% |
| October 31, 2023 | 99.84% |
| September 30, 2023 | 99.82% |
| August 31, 2023 | 99.82% |
| July 31, 2023 | 99.79% |
| June 30, 2023 | 99.75% |
| May 31, 2023 | 99.73% |
| April 30, 2023 | 99.73% |
| March 31, 2023 | 99.65% |
| February 28, 2023 | 99.42% |
| January 31, 2023 | 98.30% |
| December 31, 2022 | 98.30% |
| November 30, 2022 | 98.10% |
| October 31, 2022 | 97.75% |
| September 30, 2022 | 97.54% |
| August 31, 2022 | 96.23% |
| July 31, 2022 | 95.95% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Agenus, Inc. | 98.84% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Amgen, Inc. | 24.86% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -96.94 |
| Beta (5Y) | -0.1437 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 108.9% |
| Historical Sharpe Ratio (5Y) | -0.9025 |
| Historical Sortino (5Y) | -1.337 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 70.35% |